| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 9.646.499 $ | 95,56 | 172.477 | |||||||
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 795.051 $ | 7,88 | 3.459 | |
| Gilead Sciences Inc | Gilead Sciences Inc | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 544.949 $ | 5,40 | 4.165 | |
| Edwards Lifesciences Corp | Edwards Lifesciences Corp | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 478.121 $ | 4,74 | 5.726 | |
| Amgen Inc | Amgen Inc | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 464.668 $ | 4,60 | 1.342 | |
| Merck & Co Inc | Merck & Co Inc | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 395.232 $ | 3,92 | 3.620 | |
| Biogen Inc | Biogen Inc | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 366.257 $ | 3,63 | 1.935 | |
| Wuxi Biologics Cayman Inc | Wuxi Biologics Cayman Inc | EC | KYG970081173 | Long | Modellwert (Stufe 2) | 324.729 $ | 3,22 | 76.000 | |
| Waters Corp | Waters Corp | EC | 941848103 | Long | Börsenkurs (Stufe 1) | 320.053 $ | 3,17 | 1.035 | |
| Mettler-Toledo International Inc | Mettler-Toledo International Inc | EC | 592688105 | Long | Börsenkurs (Stufe 1) | 312.769 $ | 3,10 | 245 | |
| Intuitive Surgical Inc | Intuitive Surgical Inc | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 297.904 $ | 2,95 | 651 | |
| Charles River Laboratories International Inc | Charles River Laboratories International Inc | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 297.708 $ | 2,95 | 1.783 | |
| Vertex Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 294.892 $ | 2,92 | 690 | |
| Argenx SE | Argenx SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 287.673 $ | 2,85 | 368 | |
| Moderna Inc | Moderna Inc | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 266.636 $ | 2,64 | 5.804 | |
| Pfizer Inc | Pfizer Inc | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 250.793 $ | 2,48 | 9.393 | |
| Danaher Corp | Danaher Corp | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 250.172 $ | 2,48 | 1.398 | |
| Bruker Corp | Bruker Corp | EC | 116794108 | Long | Börsenkurs (Stufe 1) | 234.540 $ | 2,32 | 6.389 | |
| Novartis AG | Novartis AG | EC | CH0012005267 | Long | Modellwert (Stufe 2) | 233.360 $ | 2,31 | 1.579 | |
| Bio-Techne Corp | Bio-Techne Corp | EC | 09073M104 | Long | Börsenkurs (Stufe 1) | 210.493 $ | 2,09 | 3.805 | |
| Dexcom Inc | Dexcom Inc | EC | 252131107 | Long | Börsenkurs (Stufe 1) | 208.008 $ | 2,06 | 3.493 | |
| GSK PLC | GSK PLC | EC | 37733W204 | Long | Börsenkurs (Stufe 1) | 205.369 $ | 2,03 | 3.926 | |
| Protagonist Therapeutics Inc | Protagonist Therapeutics Inc | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 201.008 $ | 1,99 | 2.031 | |
| Thermo Fisher Scientific Inc | Thermo Fisher Scientific Inc | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 195.416 $ | 1,94 | 408 | |
| Roche Holding AG | Roche Holding AG | EC | CH1499059983 | Long | Modellwert (Stufe 2) | 181.745 $ | 1,80 | 446 | |
| Insmed Inc | Insmed Inc | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 180.774 $ | 1,79 | 1.326 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 163.949 $ | 1,62 | 875 | |
| UCB SA | UCB SA | EC | BE0003739530 | Long | Modellwert (Stufe 2) | 159.563 $ | 1,58 | 586 | |
| Cogent Biosciences Inc | Cogent Biosciences Inc | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 157.225 $ | 1,56 | 4.393 | |
| Incyte Corp | Incyte Corp | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 156.719 $ | 1,55 | 1.645 | |
| IDEXX Laboratories Inc | IDEXX Laboratories Inc | EC | 45168D104 | Long | Börsenkurs (Stufe 1) | 143.565 $ | 1,42 | 256 | |
| Boston Scientific Corp | Boston Scientific Corp | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 140.280 $ | 1,39 | 2.435 | |
| Bristol-Myers Squibb Co | Bristol-Myers Squibb Co | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 131.420 $ | 1,30 | 2.169 | |
| BioMarin Pharmaceutical Inc | BioMarin Pharmaceutical Inc | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 122.915 $ | 1,22 | 2.280 | |
| Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries Ltd | EC | 881624209 | Long | Börsenkurs (Stufe 1) | 118.747 $ | 1,18 | 3.386 | |
| Revolution Medicines Inc | Revolution Medicines Inc | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 104.199 $ | 1,03 | 723 | |
| Alcon AG | Alcon AG | EC | CH0432492467 | Long | Börsenkurs (Stufe 1) | 101.823 $ | 1,01 | 1.360 | |
| Summit Therapeutics Inc | Summit Therapeutics Inc | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 75.260 $ | 0,75 | 3.507 | |
| Medline Inc | Medline Inc | EC | 58507V107 | Long | Börsenkurs (Stufe 1) | 64.882 $ | 0,64 | 1.459 | |
| Dianthus Therapeutics Inc | Dianthus Therapeutics Inc | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 57.158 $ | 0,57 | 651 | |
| BioNTech SE | BioNTech SE | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 52.449 $ | 0,52 | 507 | |
| Apogee Therapeutics Inc | Apogee Therapeutics Inc | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 47.745 $ | 0,47 | 576 | |
| Sagimet Biosciences Inc | Sagimet Biosciences Inc | EC | 786700104 | Long | Börsenkurs (Stufe 1) | 13.555 $ | 0,13 | 1.688 | |
| Erasca Inc | Erasca Inc | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 13.323 $ | 0,13 | 1.251 | |
| Eikon Therapeutics Inc | Eikon Therapeutics Inc | EC | 282564103 | Long | Börsenkurs (Stufe 1) | 12.048 $ | 0,12 | 1.253 | |
| Ultragenyx Pharmaceutical Inc | Ultragenyx Pharmaceutical Inc | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 11.357 $ | 0,11 | 460 | |
| 9.646.499 $ | 95,56 | 172.477 |